Literature DB >> 26803808

Radiation de-intensification for patients with glioblastoma and poor prognostic features--how much do we really know?

Brian Michael Alexander1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26803808      PMCID： PMC4724187          DOI： 10.1093/neuonc/nov311

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  An analysis of dose-effect relationship in the radiotherapy of malignant gliomas.

Authors:  M D Walker; T A Strike; G E Sheline
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-10       Impact factor: 7.038

2.  Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.

Authors:  Nils D Arvold; Shyam K Tanguturi; Ayal A Aizer; Patrick Y Wen; David A Reardon; Eudocia Q Lee; Lakshmi Nayak; Laura W Christianson; Margaret C Horvath; Ian F Dunn; Alexandra J Golby; Mark D Johnson; Elizabeth B Claus; E Antonio Chiocca; Keith L Ligon; Brian M Alexander
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

3.  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Authors:  Annika Malmström; Bjørn Henning Grønberg; Christine Marosi; Roger Stupp; Didier Frappaz; Henrik Schultz; Ufuk Abacioglu; Björn Tavelin; Benoit Lhermitte; Monika E Hegi; Johan Rosell; Roger Henriksson
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

4.  International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.

Authors:  Wilson Roa; Lucyna Kepka; Narendra Kumar; Valery Sinaika; Juliana Matiello; Darejan Lomidze; Dalenda Hentati; Douglas Guedes de Castro; Katarzyna Dyttus-Cebulok; Suzanne Drodge; Sunita Ghosh; Branislav Jeremić; Eduardo Rosenblatt; Elena Fidarova
Journal:  J Clin Oncol       Date:  2015-09-21       Impact factor: 44.544

5.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Authors:  W Roa; P M A Brasher; G Bauman; M Anthes; E Bruera; A Chan; B Fisher; D Fulton; S Gulavita; C Hao; S Husain; A Murtha; K Petruk; D Stewart; P Tai; R Urtasun; J G Cairncross; P Forsyth
Journal:  J Clin Oncol       Date:  2004-03-29       Impact factor: 44.544

6.  Radiotherapy for glioblastoma in the elderly.

Authors:  Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Anne Bissery; Jean-Yves Delattre
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

7.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.